Press Releases

SAN DIEGO, Dec. 6, 2019 /PRNewswire/ -- Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed its fifth late-stage drug asset: Vosaroxin from Sunesis Pharmaceuticals. Denovo gains global rights to develop, manufacture and commercialize Vosaroxin.

BARCELONA, Spain, Dec. 6, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today concluded more than a year of encouraging results of its AMBAR (Alzheimer Management by Albumin Replacement) clinical trial with the presentation of new neuroimaging data that show the reduction in the progression of th

NEW YORK, Dec. 6, 2019 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit filed on behalf of investors who purchased or acquired shares of Lipocine Inc. ("Lipocine" or the "Company") (NASDAQ: LPCN) from March

SILVER SPRING, Md., Dec. 6, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has

NEW YORK, Dec. 6, 2019 /PRNewswire/ -- GENYOUth, a leading youth health and wellness nonprofit dedicated to creating healthier school communities, held its  annual fundrai

THOUSAND OAKS, Calif., Dec. 6, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved AVSOLA™ (infliximab-axxq) for all approved indications of the reference product, Remicade® (infliximab): for the treatment of moderate-to-severe rheumatoid arthritis (RA), moderate-to-severe Crohn'

MEMPHIS, Tenn., Dec. 6, 2019 /PRNewswire/ -- To help kick off the 18th annual St. Jude Memphis Marathon® Weekend, Sue Kess

PHILADELPHIA, Dec. 6, 2019 /PRNewswire/ -- Proton Therapy Partners (PTP) is pleased to announce the addition of David L. Bernd to its Board of Directors. 

WASHINGTON, Dec. 6, 2019 /PRNewswire/ -- The American Society of Hematology (ASH) today released the most comprehensive set of recommendations to date aimed at establishing uniformity and global standards for clinical trial endpoints used to evaluate new therapies for sickle cell disease (SCD). The new recommendations – published in two companion papers in the

VERO BEACH, Fla., Dec. 6, 2019 /PRNewswire/ -- At Watercrest St. Lucie West Assisted Living and Memory Care, residents and asso